TVGN
Tevogen Bio Holdings Inc.
7.80$
+1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.7% | 75.4% | 31.3% | 68.2% | 35.1% | |
| 93.0% | 70.9% | 19.1% | 37.1% | 12.6% | |
| 93.0% | 70.9% | 19.1% | 37.1% | 12.6% | |
| – | – | 6.3% | 4.6% | 3.6% | |
| 315.3% | 538.7% | 1,815.2% | 292.8% | 287.9% | |
| 8.7% | 25.3% | 1,552.6% | 261.2% | 161.3% | |
| – | 3.6% | 1,470.6% | 54.3% | 45.1% | |
| 4.9% | 11.2% | 62.1% | 150.2% | 76.2% | |
| 306.6% | 507.8% | 258.3% | 28.9% | 100.4% | |
| -215.3% | -438.7% | -1,715.2% | -192.8% | -187.9% | |
| -223.8% | -506.3% | -1,810.1% | -3,275.4% | -3,186.4% | |
| 12.5% | 31.0% | 60.1% | 84.7% | 75.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.